Business News In Brief
This article was originally published in The Gray Sheet
Executive Summary
Roche snaps up BioImagene: Digital pathology laboratory equipment maker BioImagene is acquired by diagnostics firm Roche for $100 million under an agreement announced Aug. 23. BioImagene systems generate high-resolution, whole-slide digital images from glass microscope slides and incorporate software for image analysis. The deal builds on Roche's $3.4 billion acquisition in 2008 of tissue-based cancer test maker Ventana Medical Systems (1"The Gray Sheet" Jan. 28, 2008). By adding privately held BioImagene, Roche/Ventana "is uniquely positioned to improve laboratory efficiency and help pathologists improve patient care," the company said. "With BioImagene's current and future products, we will be able to deliver an end-to-end solution from automated staining to comprehensive patient reports.